U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Drug Development Considerations for the Prevention of Healthcare-Associated Infections - 08/30/2022
  1. News & Events for Human Drugs

Workshop | Virtual

Event Title
Drug Development Considerations for the Prevention of Healthcare-Associated Infections
August 30, 2022

Date:
August 30, 2022
Time:
8:30 a.m. - 5:00 p.m. ET

Event Summary

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) co-sponsored this public virtual workshop on August 30, 2022.

The following topics were discussed:

  • The current state of development of pathogen-directed products used to prevent healthcare-associated infections
  • Evidence supporting decolonization and pathogen reduction (in colonized patients) as a strategy to prevent infection and transmission of antimicrobial-resistant healthcare-associated pathogens
  • Antimicrobial resistance threats as potential targets for decolonization and pathogen reduction
  • Challenges and potential approaches to drug development and registration of products for the prevention of healthcare-associated infections

Event Recording

Video transcript

Back to Top